IPSC vs K · rev $6.6M vs P/E 23, $29.03B cap
Century Therapeutics Inc (IPSC) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
K does not have a complete income-statement cache yet.
IPSC currently screens at market cap $47.8M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the IPSC and K stock pages for the full models.
Not investment advice.